Acura Pharmaceuticals (ACUR) - FDA decision on Acurox approval to be announced today

ACUR stock has suffered some serious blows in the past 10 days, as 1) early investors pulled out and booked profit and 2) many began to doubt the approval of ACUR's abuse-deterrent pain killer, Acurox (previously met with regulatory obstacles).  We will soon find out the final outcome.  If a complete response letter (CRL) is issued, then expect ACUR to drop to $2 - 2.5.  If approval is announced, then expect ACUR to surge to $5 - 5.2 (25 - 30% pop from $4).

My plan is simple:

On REJECTION, I will simply move on without losing a penny.

On APPROVAL, I will purchase CHEAP July $5 or $7.5 puts in anticipation of a quick sell-off (remember, Friday's approvals almost always don't end well; **OPTR)

Follow me on Twitter (@Michaeljuan01) for trading updates.  Good luck!